Advertisement
Prostate-specific antigen levels in midlife predict future lethal prostate cancer risk

Midlife PSA Levels Predict Future Lethal Prostate Cancer

0
PSA levels in midlife strongly predict future lethal prostate cancer risk in U.S. cohort
For men with prostate cancer

SBRT, Proton Beam Therapy Use Increasing for Prostate CA

0
Median cost of stereotactic body radiotherapy lower than IMRT or proton beam therapy
Helicobacter pylori infection is associated with metabolic syndrome

Review Links H. pylori Infection With Metabolic Syndrome

0
Infection also linked to higher triglycerides, fasting blood glucose, BMI, HOMA-IR, systolic BP, lower HDL
Persistent depressive symptoms are associated with increased coronary artery calcium scores among middle-aged women without cardiovascular disease

Persistent Depression Linked to Increased CAC Scores in Women

0
Increased coronary artery calcium in middle-aged women without cardiovascular disease, diabetes
Many young people who suffer from migraines have vitamin deficiencies

Young Migraine Patients Often Have Vitamin Deficiencies

0
But study couldn't determine if supplements made a difference
Intensive blood glucose control appears to reduce the risk of retinopathy progression in patients with type 2 diabetes

Intensive HbA1c Control Cuts Diabetic Retinopathy Progression

0
Patients with type 2 diabetes reduced their risk by half with intensive management
American seniors with diabetes are starting to live longer without disabilities

American Seniors With Diabetes Living Longer Without Disability

0
Researchers find increase in 'good' years of life in recent decades
More than half of patients prescribed opioids receive more than they need

Many Patients Prescribed Opioids Sharing Leftover Pills

0
Two new U.S. studies shed additional light on opioid epidemic
The use of ambulance diversion for temporarily relieving emergency departments remains a critical issue across the country

Ambulance Diversion Still a Concern Across the United States

0
Ambulance diversion linked to delays in treatment; seems ineffective for addressing overcrowding
Genetic variants in CYP2C8 and SLCO1B1 impact the therapeutic response to rosiglitazone in patients with type 2 diabetes

CYP2C8, SLCO1B1 Variants Impact Response to Rosiglitazone

0
Genetic variants have clinical impact on response to rosiglitazone, but not pioglitazone